Study of the serum level of fasting glucagon-like peptide-1 in type 2 diabetics and its relation to the glycemic profile
Background Glucagon-like peptide-1 (GLP-1) is a peptide formed of 30 amino acids. It is synthesized in and released from the enteroendocrine L cells that are present throughout the small and the large intestine. Because of the important physiological role of GLP-1 in augmenting insulin secretion, it...
Saved in:
Main Authors: | Mohamed A Korani (Author), Ahmed Sonbol (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes
by: Seungah Lee, et al.
Published: (2017) -
The relation between plasma levels of nesfatin-1 and different grades of diabetic kidney disease in patients with type 2 diabetes
by: Mohamed A Korani, et al.
Published: (2018) -
Effect of Salt Intake on Serum Glucagon-Like Peptide-1 Levels in Normotensive Salt-Sensitive Subjects
by: Wen-Ling Zheng, et al.
Published: (2017) -
Serum Ghrelin and Glucagon-like Peptide 1 Levels in Children with Prader-Willi and Bardet-Biedl Syndromes
by: Doğa Türkkahraman, et al.
Published: (2024) -
Effect of Glucagon-like peptide-1 receptor agonists on dyslipidemia in type 2 diabetes
by: Elizabeth A. Cristiano, et al.
Published: (2020)